Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02720601
What this trial is testing

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
New Mexico Cancer Research Alliance
Not applicableStudy completedNCT01589328
What this trial is testing

Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB

Who this might be right for
Pancreatic CancerBiliary Tract CancerCancer Pain+1 more
National Cancer Center, Korea 288
Testing effectiveness (Phase 2)Study completedNCT01534637
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerNauseaVomiting+3 more
Wake Forest University Health Sciences 22
Testing effectiveness (Phase 2)Study completedNCT01845337
What this trial is testing

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

Who this might be right for
Gastrointestinal CancerCancer of Unknown Primary SitePancreatic Cancer+1 more
University of Edinburgh 59
Post-approval studies (Phase 4)Looking for participantsNCT07790445
What this trial is testing

A Prospective, Open-Label, Randomized Controlled Clinical Study Comparing Hepatic Arterial Infusion Chemotherapy (HAIC) With Capecitabine as Adjuvant Therapy After Radical Surgery for Malignant Biliary Tract Tumors

Who this might be right for
Malignant Biliary Tract Tumors
Zhai Wenlong 90
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Not applicableEnded earlyNCT04276090
What this trial is testing

Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct NeoplasmsColorectal Neoplasms
Michael J Cavnar, MD 21
Not applicableStudy completedNCT05429203
What this trial is testing

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Who this might be right for
Biliary DiseasePancreatic DiseaseCholedocholithiasis+3 more
Stanford University 319
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05564403
What this trial is testing

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Gallbladder CarcinomaAdvanced Intrahepatic Cholangiocarcinoma+14 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT01284413
What this trial is testing

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 68
Not applicableUnknownNCT02715089
What this trial is testing

Precise Treatment in Hepatobiliary Cancers (PTHBC)

Who this might be right for
Liver NeoplasmsBiliary Tract NeoplasmsHepatobiliary Neoplasms
Peking Union Medical College Hospital 30
Early research (Phase 1)Looking for participantsNCT07107750
What this trial is testing

Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract CancerMetastatic Biliary Tract Carcinoma
Washington University School of Medicine 48
Not applicableWithdrawnNCT00588263
What this trial is testing

Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+7 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03044587
What this trial is testing

Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer

Who this might be right for
Adenocarcinoma MetastaticBiliary Tract CancerAdenocarcinoma of the Biliary Tract+4 more
AIO-Studien-gGmbH 93
Not applicableActive Not RecruitingNCT06531408
What this trial is testing

Predicting Incidental Gallbladder Cancer

Who this might be right for
Gallbladder Cancer
University Hospital Plymouth NHS Trust 30,000
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Not applicableUnknownNCT05418543
What this trial is testing

CH-EUS in Diagnosis of Inoperable Bile Duct Tumors

Who this might be right for
Inoperable DiseaseBile Duct Cancer
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor 40
Testing effectiveness (Phase 2)UnknownNCT05911425
What this trial is testing

Combined Treatment of Treated Bile Duct Cancer

Who this might be right for
Bile Duct Cancer
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03524508
What this trial is testing

Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer

Who this might be right for
Metastatic Biliary Tract Cancer
Changhoon Yoo 178
Next Page